157 Aufrufe 157 0 Kommentare 0 Kommentare

    Hims & Hers Completes Acquisition of Eucalyptus, Parent Company of Juniper, Officially Entering Japanese Market

    Hims & Hers Completes Acquisition of Eucalyptus, Parent Company of Juniper, Officially Entering Japanese Market

    Hims & Hers Health, Inc. has completed its acquisition of Eucalyptus, the parent company of Juniper, marking a significant milestone in the company's global growth and its formal entry into Japan. This milestone puts the full weight of Hims & Hers’ technology, data, and clinical infrastructure behind a platform that supports weight management care for people in Japan, a market the company approaches with deep respect for its distinct healthcare values and the trust people place in those who serve them.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260602317273/en/

    Anzeige 
    Handeln Sie Ihre Einschätzung zu Hims & Hers Health Registered (A)!
    Long
    30,18€
    Basispreis
    0,40
    Ask
    × 8,70
    Hebel
    Zum Produkt
    Blatt
    Short
    35,94€
    Basispreis
    0,37
    Ask
    × 7,32
    Hebel
    Zum Produkt
    Blatt
    Präsentiert von
    Im Durchschnitt erleiden 7 von 10 Kleinanlegern Verluste beim Handel mit Turbo-Zertifikaten. Turbo-Zertifikate sind hoch risikoreiche Produkte und nicht für langfristige Anlagestrategien geeignet.
    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.
    Closing brings the scale, technology and clinical infrastructure of Hims & Hers to Japan

    Closing brings the scale, technology and clinical infrastructure of Hims & Hers to Japan

    Juniper entered Japan in November 2023, and has since become a trusted partner to eligible local customers seeking support in their weight loss journey. In a market where people with weight-related concerns wait an average of six years to seek support for weight loss care, Juniper has built a steady customer base by offering an evidence-based path to care.

    “In Japan, the need for accessible, quality weight management care has long outpaced what's available. Juniper has already started to change that,” said Andrew Dudum, co-founder and CEO of Hims & Hers. “Hims & Hers is here to accelerate that change, bringing the full scale of our platform behind a team that has already earned the trust of Japanese customers, and a shared commitment to support their lifelong health journeys.”

    To best serve its customers in Japan, Hims & Hers will continue to invest in a local clinical approach, and customers will continue to be connected with Japanese providers who understand the healthcare landscape they're navigating, and bring the local expertise and clinical rigour this kind of care demands.

    As Hims & Hers grows in Japan, continuity of care is a top priority. For customers who have received care through Juniper, their treatment continues uninterrupted as the brand grows. Joining Hims & Hers gives the team in Japan the backing to keep building on a model that patients have come to trust, with more resources and reach behind it.

    “Trust is everything in Japanese healthcare, and it has to be earned,” said Ryan Nolan, Vice President of International at Juniper. “Juniper spent two years doing exactly that, building a standard of weight care that customers here can genuinely rely on. Now through Hims & Hers, we have the global scale and clinical depth to take that work further, providing access to the evidence-based, high-quality, judgment-free care they deserve.”

    Seite 1 von 3 





    Business Wire (engl.)
    0 Follower
    Autor folgen

    Hims & Hers Completes Acquisition of Eucalyptus, Parent Company of Juniper, Officially Entering Japanese Market Hims & Hers Health, Inc. has completed its acquisition of Eucalyptus, the parent company of Juniper, marking a significant milestone in the company's global growth and its formal entry into Japan. This milestone puts the full weight of Hims & Hers’ …

    Im Durchschnitt erleiden 7 von 10 Kleinanlegern Verluste beim Handel mit Turbo-Zertifikaten. Turbo-Zertifikate sind hoch risikoreiche Produkte und nicht für langfristige Anlagestrategien geeignet.
    Profitieren Sie von unserem Alleinstellungsmerkmal als den zentralen verlagsunabhängigen Wissens-Hub für einen aktuellen und fundierten Zugang in die Börsen- und Wirtschaftswelt, um strategische Entscheidungen zu treffen.
    • ✅ Größte Finanz-Community Deutschlands
    • ✅ über 550.000 registrierte Nutzer
    • ✅ rund 2.000 Beiträge pro Tag
    • ✅ verlagsunabhängige Partner ARIVA, FinanzNachrichten und BörsenNews
    • ✅ Jederzeit einfach handeln beim SMARTBROKER+
    • ✅ mehr als 25 Jahre Marktpräsenz
    Aktien von A - Z: # A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
    wallstreetONLINE bei X wallstreetONLINE bei Instagram wallstreetONLINE bei Facebook wallstreetONLINE bei Youtube wallstreetONLINE bei LinkedIn
    Unsere Apps: Apple App Store Icon Google Play Store Icon
    Wenn Sie Kursdaten, Widgets oder andere Finanzinformationen benötigen, hilft Ihnen ARIVA gerne. 

    Unsere User schätzen wallstreet-online.de: 4.8 von 5 Sternen ermittelt aus 285 Bewertungen bei www.kagels-trading.de
    Zeitverzögerung der Kursdaten: Deutsche Börsen +15 Min. NASDAQ +15 Min. NYSE +20 Min. AMEX +20 Min. Dow Jones +15 Min. Alle Angaben ohne Gewähr.
    Copyright © 1998-2026 Smartbroker Holding AG - Alle Rechte vorbehalten.
    Mit Unterstützung von: Ariva Smartbroker+
    Daten & Kurse von: TTMzero